Navigation Links
When blood pressure refuses to go down
Date:11/11/2011

Five to 15 percent of all patients with hypertension fail to respond to drug treatment. However, a range of treatment options are now available in these cases. Alongside the established measures stand new and promising interventions such as renal sympathetic denervation. Felix Mahfoud, Frank Himmel and their co-authors present the current treatment strategies for resistant arterial hypertension in the latest issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2011; 108(43): 725).

A multimodal interdisciplinary strategy is necessary for the successful treatment of resistant arterial hypertension. Drug treatment must be tailored to the individual patient, and reversible or secondary causes of hypertension must be systematically sought and treated. The important non-pharmacological conservative treatment measures include optimization of weight, a low-salt diet, physical exercise, and abstinence from alcohol.

Minimally invasive renal denervation and baroreceptor stimulation are two alternative treatment options for selected patients with resistant arterial hypertension. Renal sympathetic denervation is an interventional procedure with a low rate of complications that can bring about a significant and enduring reduction in blood pressure. For conclusive evaluation of the long-term effects and safety of this new approach, patients have to be enrolled in clinical registries and monitored at regular intervals following treatment. In Germany, the German Renal Denervation (GREAT) Registry has been set up for this purpose.

Arterial hypertension is among the most common chronic diseases in the western industrialized nations and is a major risk factor for cardiovascular morbidity and mortality.
'/>"/>

Contact: Dr. med. Felix Mahfoud
felix.mahfoud@uks.eu
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Maternal Blood Test Might Spot Birth Defects More Safely
2. Fecal occult blood testing effective in colonoscopy screenings
3. Obese monkeys lose weight on drug that attacks blood supply of fat cells
4. Tear drops may rival blood drops in testing blood sugar in diabetes
5. Breakthrough in understanding the genetics of high blood pressure
6. Clemson researcher says high blood pressure may lead to missed emotional cues
7. Benefits of nut consumption for people with abdominal obesity, high blood sugar, high blood pressure
8. Mini Stem Cell Transplant May Help Seniors With Blood Cancer
9. Virginia Commonwealth University findings may help explain high blood pressure in pregnancy
10. Fast new method for mapping blood vessels may aid cancer research
11. Newer Pill May Raise Blood Clot Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... CA (PRWEB) May 28, 2015 Cosmetic ... of plastic surgeons and patients alike. You can find ... breast augmentation, and body contouring. Readers can directly connect ... streamlined user experience from the ground up. , The ... is allowing the community to grow and getting it ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
(Date:5/28/2015)... CA (PRWEB) May 28, 2015 The USC ... outpatient wound center management for a decade with a current ... was formed between USC and Wound Care Advantage to provide ... recognized for a drop in the rate of ... , Wound healing is a complex undertaking that can frighten ...
(Date:5/28/2015)... Bronx, NY (PRWEB) May 28, 2015 ... Urgent Care are proud to present Dr. Alicia Almendral ... will be a big part of the newly opened ... very finest in modern cosmetic treatments. , Dr. Almendral ... experienced in the latest anti-aging and cosmetic enhancement techniques. ...
(Date:5/28/2015)... 28, 2015 AMVETS National Executive Director ... Commission on Care established by Congress to examine how ... , Appointed to the commission by Mitch McConnell, majority ... one of only 15 voting members on the panel, ... Accountability Act of 2014. The goal of the commission ...
Breaking Medicine News(10 mins):Health News:New York Cosmetic Doctors Now in Cosmetic Town 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 3Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2
... surgery, which is used to treat Parkinsons disease and ... potential to treat a variety of conditions. For example, ... cluster headaches and aggressiveness in humans, and stimulating this ... found that hypothalamic DBS performed in the treatment of ...
... the radiocarbon dating method and special proteins in the lens ... Aarhus can now establish, with relatively high precision, when a ... scientists who can use it to establish the date of ... consequences for health science research. The findings are published in ...
... preventable source of death and disability in the USA, contributing ... the health dangers, 1 in 8 American adults is ... scientists have known that most of the risk for habitual ... by genetics. This conclusion comes from the study of ...
... degree program addresses growing mental health workforce,crisis, ... the,growing mental health workforce crisis, California Institute of ... program in,Community Mental Health in fall 2008., ... Psychology with a,concentration in Community Mental Health, as ...
... A drug used to treat kidney cancer also targets a ... acute myeloid leukemia (AML), the most common and lethal form ... D. Anderson Cancer Center report in the Jan. 29 edition ... a Phase I clinical trial, the drug sorafenib reduced the ...
... Adjusted net income increases 84% to $250 million ... December 31, 2007 as,follows:, , (US$ in millions, except EPS) ... Periods ... Ended ...
Cached Medicine News:Health News:Deep brain stimulation may improve memory 2Health News:The eyes have it 2Health News:DNA (driver of nicotine addiction) 2Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 2Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 3Health News:Kidney cancer drug attacks a major type of acute myeloid leukemia 2Health News:Kidney cancer drug attacks a major type of acute myeloid leukemia 3Health News:Flextronics Announces Third Quarter Results 2Health News:Flextronics Announces Third Quarter Results 3Health News:Flextronics Announces Third Quarter Results 4Health News:Flextronics Announces Third Quarter Results 5Health News:Flextronics Announces Third Quarter Results 6Health News:Flextronics Announces Third Quarter Results 7Health News:Flextronics Announces Third Quarter Results 8Health News:Flextronics Announces Third Quarter Results 9Health News:Flextronics Announces Third Quarter Results 10Health News:Flextronics Announces Third Quarter Results 11Health News:Flextronics Announces Third Quarter Results 12Health News:Flextronics Announces Third Quarter Results 13Health News:Flextronics Announces Third Quarter Results 14Health News:Flextronics Announces Third Quarter Results 15Health News:Flextronics Announces Third Quarter Results 16Health News:Flextronics Announces Third Quarter Results 17Health News:Flextronics Announces Third Quarter Results 18Health News:Flextronics Announces Third Quarter Results 19
(Date:5/28/2015)... 2015  Eli Lilly and Company (NYSE: LLY ) ... tender offer for up to $1.6 billion aggregate principal amount ... of notes who tendered, and did not validly withdraw, their ... City time, on May 27, 2015 (the early ... are eligible to receive the total consideration. The total consideration ...
(Date:5/28/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... with buyers to divest in the United ... assets, Biomet Discovery® Elbow System assets and Cobalt™ bone ... Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... constructively with the Bureau of Competition Staff of the ...
(Date:5/28/2015)... , May 28, 2015 /PRNewswire/ - ESSA Pharma Inc. ... for the second quarter and three and six months ended ... Canadian dollars and in accordance with International Financial Reporting Standards ... recorded a net loss of $5.9 million ($0.35 per common ... compared to a net loss of $0.4 million ($0.03 per ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 4 Thoratec Corporation (Nasdaq: THOR ), a world ... and restore failing hearts, said today that revenues for the ... of nine percent over revenues of $80.8 million in the ... reflect a 14 percent increase in revenues from the company,s ...
... YORK, Nov. 4 NeoStem, Inc. (NYSE Amex: ... has been named to the Company,s Board of Directors. ... operating global biotechnology businesses. , Serving as Executive Vice ... global commercial operations of Abraxis Bioscience, a global biotechnology ...
Cached Medicine Technology:Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 2Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 3Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 4Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 5Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 6Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 7Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 8Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 9Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 10Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 11Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 12Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 13Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 14Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 15Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 16Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 17Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 18Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 19NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 2NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: